RACHELLE DOODY to Drug Approval
This is a "connection" page, showing publications RACHELLE DOODY has written about Drug Approval.
Connection Strength
1.545
-
Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment? J Prev Alzheimers Dis. 2023; 10(3):344-345.
Score: 0.826
-
Editorial: Consequences of the FDA Decision on Aducanumab for Patient Care and Research. J Prev Alzheimers Dis. 2021; 8(4):393-395.
Score: 0.719